[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614211":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":26,"locations":35,"responsibleParty":51,"collaborators":23,"id":55,"slug":23,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":23,"eligibilityCriteria":60,"healthyVolunteers":61,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":23,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":38,"whyStopped":23,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Zagazig University","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Retrosuperior costotransverse ligament block group","ACTIVE_COMPARATOR","The patient will receive retrosuperior costotransverse ligament block",[13],"Procedure: Retrosuperior costotransverse ligament block group",{"label":15,"type":10,"description":16,"interventionNames":17},"Erector spinae block group","The patient will receive erector spinae block.",[18],"Procedure: Erector spinae block group",[20,24],{"type":21,"name":9,"description":11,"armGroupLabels":22,"otherNames":23},"PROCEDURE",[9],null,{"type":21,"name":15,"description":16,"armGroupLabels":25,"otherNames":23},[15],[27,32],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":23},"Dina Salem, MD","CONTACT","01099333513","002",{"name":33,"role":29,"phone":34,"phoneExt":31,"email":23},"Marwa Medhat, MD","01002828937",[36],{"facility":37,"status":38,"city":39,"state":23,"zip":23,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Faculty of human medicine, Zagazig university, Zagazig","RECRUITING","Zagazig","Egypt","EG",{"type":43,"coordinates":44},"Point",[45,46],31.502,30.58768,{"lat":46,"lon":45},[49],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":50},"dinamaghraby@yahoo.com",{"type":52,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"PRINCIPAL_INVESTIGATOR","Dina Abdelhameed Elsadek Salem","Associate professor","100614211",false,"NCT07276646","Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy","Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy: A Randomized Clinical Trial.","Inclusion Criteria:\n\n1. patient acceptance\n2. Age: 21-64 years old.\n3. Sex: both sexes.\n4. Physical status: ASA I \\& II.\n5. Body mass index (BMI): 18.5 - 30 kg\u002Fm2.\n6. Type of operations: elective laparoscopic cholecystectomy.\n7. Duration of surgery not more than 2 hours.\n\nExclusion Criteria:\n\n1. Known hypersensitivity to lidocaine or bupivacaine.\n2. Patients with respiratory insufficiency.\n3. Coagulation disorders or taking drugs affect surgical hemostasis.\n\n7\\. Patients with pre-existing neurological deficits. 8. Uncooperative patient or with altered mental status. 9. Patient with advanced cardiovascular or respiratory diseases",true,"ALL","21 Years","64 Years",{"count":66,"type":67},80,"ESTIMATED","INTERVENTIONAL",[70],"NA","This study aims to compare the analgesic effect of retro superior costotransverse ligament space block vs erector spinae plane block to Achieve high-quality perioperative opioid-sparing effect and postoperative analgesia after laparoscopic cholecystectomy with optimum hemodynamic stability and high patient and surgeon satisfaction",[73],"Perioperative Analgesia",[75,76,77],"retrosuperior costotransverse ligament block","erector spinae block","laparoscopic cholecystectomy","2025-12-11",{"date":80,"type":81},"2025-12-12","ACTUAL",{"date":83,"type":81},"2025-12-10",{"date":85,"type":67},"2026-07-10",{"name":5,"class":6},1]